Td Asset Management Inc Aurinia Pharmaceuticals Inc. Transaction History

Td Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$10.93 - $23.55 $3.45 Million - $7.44 Million	-315,979 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$10.0 - $14.52 $644,800 - $936,249	-64,480 Reduced 16.95%	315,979 $4.24 Million
Q1 2021 May 14, 2021	SELL	$12.3 - $18.73 $1.89 Million - $2.88 Million	-153,768 Reduced 28.78%	380,459 $4.95 Million
Q4 2020 Feb 16, 2021	BUY	$12.94 - $16.05 $840,634 - $1.04 Million	64,964 Added 13.84%	534,227 $7.36 Million
Q3 2020 Nov 10, 2020	BUY	$13.19 - $16.66 $402,769 - $508,729	30,536 Added 6.96%	469,263 $6.89 Million
Q2 2020 Aug 13, 2020	BUY	$14.12 - $18.33 $3.68 Million - $4.78 Million	260,631 Added 146.34%	438,727 $7.1 Million
Q1 2020 May 15, 2020	BUY	$11.34 - $21.46 $2.02 Million - $3.82 Million	178,096 New	178,096 $2.56 Million

211

58.4M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.17B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.